Davide Turco
Managing Partner @ Atlante Ventures
Milano, Italy
Davide Turco is a seed investor at Atlante Ventures in Milano focused on Biotechnology and Therapeutics. Davide Turco joined Indaco Venture Partners as Co-Founder & Managing Director.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries Davide Turco invests in
Stages Davide Turco invests in
Countries Davide Turco invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 4 (31%)
- Therapeutics 2 (15%)
- Delivery 1 (8%)
- Hardware 1 (8%)
- Hospital 1 (8%)
Stage
- Seed 2 (15%)
- Series A 2 (15%)
- Series B 2 (15%)
- Funding Round 2 (15%)
- Venture - Series Unknown 1 (8%)
Country
- Italy 4 (31%)
- Switzerland 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies. | $14.2M / Series B / Feb 13, 2025 | ||
| TES Pharma is a research-based biopharmaceutical company focusses on delivering first in class preclinical candidates that unlock the potential of novel therapeutic targets and mechanisms. | $5.2M / Series A / Dec 19, 2024 | ||
| MicThera focuses on developing microbial-derived therapeutics to provide effective treatments for prostate cancer patients, aiming to find effective solutions for medical companies. | $1.1M / Seed / May 30, 2024 | ||
| WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | $7.1M / Series B / May 25, 2017 | ||
| WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | $3.4M / Series A / Jun 09, 2015 | ||
| WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | Venture - Series Unknown / Jul 11, 2014 | ||
| Tethis is a bio- and nanotechnology company. | Feb 28, 2014 | ||
| WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | Seed / Nov 08, 2013 | ||
| WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | May 11, 2013 | ||
| Tethis is a bio- and nanotechnology company. | Feb 28, 2013 | ||
| See all 13 investments → | |||
Co-Investors
About Atlante Ventures
Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.
Atlante Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alberto Villa
Investment Analyst
|
|||
Alvise Bonivento
Senior Investment Manager
|
|||
Giovanni De Caro
Investment Manager
|
|||
Andrea Ballestri
Investment Director
|
|||
|
Antonella Beltrame
Investment Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Davide Turco invest in?
Davide Turco invests primarily in Biotechnology, Therapeutics and Delivery startups, most often at Seed and Series A stage. Most of the 13 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Davide Turco?
Public channels for Davide Turco include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Davide Turco last invest?
The most recent investment recorded for Davide Turco closed in Feb 2025. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
